BSEGeneralResults2 Nov 2026
Welcure Drugs & Pharmaceuticals Ltd
Approval of the Audited Standalone Financial Results and Audited Standalone Financial Statements
Welcure Drugs & Pharmaceuticals Ltd has approved its audited standalone financial results for the quarter and year ended March 31, 2026, with a net loss of ₹5,003.73 lakhs and ₹567.08 lakhs respectively.
Read more →📎 1 attachment